FDA
label_change
· 2020-09-25
FDA Approved: GALAFOLD — Supplemental Application (Amicus Therapeutics US, LLC)
Summary
The FDA approved a supplemental application for GALAFOLD (migalastat hydrochloride) submitted by Amicus Therapeutics US, LLC to update its labeling. This action…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for GALAFOLD (MIGALASTAT HYDROCHLORIDE)